Searchable abstracts of presentations at key conferences in endocrinology

ea0043oc56 | Translational and Preclinical Trend in Diabetes | WCTD2016

The use of modified hyperinsulinemic hypoglycaemic glucose clamp to evaluate the accuracy of blood glucose monitoring systems in T1DM patients

Fawkes Neil , Fawkes Neil , Bell David , Bell Patrick

Background and aims: The ISO guideline 15197 lays out the system accuracy (SA) and user performance (UP) evaluation requirements for BGMS for self-testing in managing diabetes mellitus. They require the measurement of blood glucose to be tested across a spectrum of glucose ranges to demonstrate accuracy, including within the hypoglycemic range. Fulfilling the requirements for accuracy evaluations at the hypoglycaemic range can be challenging. The aim of the study was to show t...

ea0037ep74 | Adrenal cortex | ECE2015

An audit of the investigation and follow up of adrenal incidentalomas

McElwaine Fred , Ellis Peter , McCance David , Bell Patrick , Hunter Steven , Courtney Hamish , Mullan Karen

An adrenal incidentaloma is defined as an adrenal mass >1 cm diameter, discovered serendipitously on radiological imaging done for another reason. They are important because a percentage will turn out to be malignant or secrete excess hormones. The aim of the current study was to ascertain if these lesions were being investigated and followed appropriately compared to American Association of Clinical Endocrinologists guidelines. All imaging reports for the calendar year 20...

ea0050p391 | Thyroid | SFEBES2017

Iodine status on the Island of Ireland

Mullan Karen , McKeever Edward , Hamill Lesley , Doolan Katie , Young Ian , Smyth Peter , Flynn Albert , Patterson Chris , Walton Janette , Meharg Andy , Graham Una , McMullan Paul , McCance David , Bell Marcia , McHugh Cathy , McQuaid Siobhan , Tuthill Antoinette , Black Neil , O'Loughlin Aonghus , Woodside Jayne

Iodine is a trace element required for thyroid hormone production. Requirements increase in pregnancy, when even mild deficiency may affect offspring neurocognitive development.The gold standard for assessing iodine status is population surveys of urinary iodine concentration (UIC). The WHO also suggests a population prevalence of >3% of TSH values > 5 mIU/L indicates deficiency. A recent UK survey of 700 teenage girls demonstrated ...

ea0050p391 | Thyroid | SFEBES2017

Iodine status on the Island of Ireland

Mullan Karen , McKeever Edward , Hamill Lesley , Doolan Katie , Young Ian , Smyth Peter , Flynn Albert , Patterson Chris , Walton Janette , Meharg Andy , Graham Una , McMullan Paul , McCance David , Bell Marcia , McHugh Cathy , McQuaid Siobhan , Tuthill Antoinette , Black Neil , O'Loughlin Aonghus , Woodside Jayne

Iodine is a trace element required for thyroid hormone production. Requirements increase in pregnancy, when even mild deficiency may affect offspring neurocognitive development.The gold standard for assessing iodine status is population surveys of urinary iodine concentration (UIC). The WHO also suggests a population prevalence of >3% of TSH values > 5 mIU/L indicates deficiency. A recent UK survey of 700 teenage girls demonstrated ...

ea0089b8 | Basic Science | NANETS2022

CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors

Kaemmer Courtney , Umesalma Shaikamjad , Maharjan Chandra , Kohlmeyer Jordan , Wilkerson Emily , Sheehy Ryan , Leidinger Mariah , Meyerholz David , Bell Sarah , Zamba Gideon , Breheny Patrick , Lattime Edmund , Chandrasekharan Chandrikha , Bellizzi Andrew , Herring Laura , Graves Lee , Darbro Benjamin , Yuan Ziqiang , Libutti Steven , Quelle Dawn

Background: New therapeutics and combinations are needed to improve the survival of patients with advanced, metastatic pancreatic NETs (pNETs). RABL6A is a novel oncogenic driver of pNET pathogenesis that acts through multiple oncogenic pathways. Kinome and phosphoproteome analyses of proliferating (RABL6A-positive) pNET cells, vs arrested (RABL6A-knockdown) controls, demonstrated that druggable cyclin-dependent kinase 4 and 6 (CDK4/6) and MEK kinases are activated in growing ...

ea0098b28 | Basic Science | NANETS2023

Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Kaemmer Courtney , Umesalma Shaikamjad , Maharjan Chandra , Kohlmeyer Jordan , Lingo Joshua , Wilkerson Emily , Sheehy Ryan , Leidinger Mariah , Meyerholz David , Bell Sarah , Zamba Gideon , Breheny Patrick , Lattime Edmund , Chandrasekharan Chandrikha , Bellizzi Andrew , Herring Laura , Graves Lee , Darbro Benjamin , Yuan Ziqiang , Libutti Steven , Quelle Dawn

Background: New effective therapies are needed to improve the survival of patients with metastatic pancreatic NETs (pNETs). RABL6A is a novel oncogenic driver of pNET pathogenesis. Kinome and phosphoproteome analyses of proliferating (RABL6A-positive) pNET cells, vs arrested (RABL6A-knockdown) controls, demonstrated that cyclin-dependent kinase 4 and 6 (CDK4/6) and MEK kinases are actionable drug targets in growing pNET cells. In agreement, published studies of patient pNETs b...